COMMUNIQUÉS West-GlobeNewswire

OPKO Health to Report First Quarter 2019 Financial Results on May 7, 2019
30/04/2019
MIAMI, April 30, 2019 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report its operating and financial results for the three months ended March 31, 2019, as well as provide guidance on expected revenues [...]
Imprivata Introduces IAM Cloud Platform for Healthcare Supported by Microsoft
30/04/2019
First phase of collaboration extends enterprise-wide single sign-on to the cloud LEXINGTON, Mass., April 30, 2019 (GLOBE NEWSWIRE) -- Imprivata® , the healthcare IT security company, today announced that it will unlock [...]
CymaBay Therapeutics to Report First Quarter 2019 Financial Results on Wednesday, May 8
30/04/2019
NEWARK, Calif., April 30, 2019 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high [...]
Tetra Natural Health Announces The Arrival of 20 containers of Hemp Energy Drink in Canada
30/04/2019
1.7 million cans to be distributed in Montreal, Toronto and Vancouver OTTAWA, April 30, 2019 (GLOBE NEWSWIRE) -- Tetra Natural Health, a subsidiary of Tetra Bio-Pharma (TSX VENTURE: TBP) (OTCQB: TBPMF), announces the [...]
Tetra Santé Naturelle annonce l'arrivée de 20 conteneurs de Hemp Energy Drink au Canada
30/04/2019
1,7 millions de canettes réparties entre Montréal, Toronto et Vancouver OTTAWA, 30 avr. 2019 (GLOBE NEWSWIRE) -- Tetra Santé Naturelle, une filiale de Tetra Bio-Pharma (TSX VENTURE: TBP) (OTCQB: TBPMF), annonce l’ [...]
Genocea Provides Corporate Update, Including First-Quarter 2019 Financial Results
30/04/2019
Company anticipates presenting first GEN-009 immunogenicity data at ASCO 2019 Conference call today at 9:00 am ET CAMBRIDGE, Mass., April 30, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc . (NASDAQ: GNCA), a [...]
Abeona Therapeutics to Report New Preclinical Data Demonstrating Therapeutic Potential of ABO-401 for Treatment of Cystic Fibrosis at American Society of Gene and Cell Therapy Annual Meeting
30/04/2019
NEW YORK and CLEVELAND, April 30, 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today will report new preclinical data demonstrating that ABO-401, [...]
HTG Molecular Expands Agreement with Illumina to Include Autoimmune, Cardiovascular, and Fibrosis Disorders and Diseases
30/04/2019
Amendment allows for the development of IVD test kits compatible with Illumina technology TUCSON, Ariz., April 30, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a diagnostic company [...]
BioVie Achieves Primary Objectives in Phase 2a Clinical Trial of BIV201 in Refractory Ascites
30/04/2019
LOS ANGELES, April 30, 2019 (GLOBE NEWSWIRE) -- BioVie Inc. (OTCQB: BIVI) (“BioVie” or “Company”), a clinical-stage company developing innovative drug therapies for liver disease, today announced top-line results for [...]
HealthLynked Corp. Announces the Addition of Bob Gasparini to its Board of Directors
30/04/2019
NAPLES, Fla., April 30, 2019 (GLOBE NEWSWIRE) -- HealthLynked Corp. (OTCQB: HLYK) today announced the addition of Bob Gasparini to its Board of Directors. Mr. Gasparini was a key executive at NeoGenomics Laboratories [...]
BioSig To Participate at Heart Rhythm Society’s Scientific Sessions 2019
30/04/2019
Santa Monica, CA, April 30, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address unmet needs for [...]
Data Published in Neurology Show that Treatment with SPINRAZA® (nusinersen) Improved Motor Function and Provided Long-Term Benefit for Individuals with Later-Onset Spinal Muscular Atrophy
30/04/2019
Patients, aged five up to 19, treated with SPINRAZA over three years demonstrated clinically significant improvements in motor function and stabilization of disease activity One individual gained the ability to walk [...]
Medtronic Announces U.S. Commercial Launch of Solitaire(TM) X Revascularization Device
30/04/2019
System Offers New Options for Improving Outcomes in Treating Stroke; World's Second-Leading Cause of Death, Third-Leading Cause of Disability DUBLIN - April 30, 2019 - Medtronic plc (NYSE:MDT) today announced the U.S. [...]
Conatus Pharmaceuticals Announces Publication Demonstrating that Emricasan Ameliorates Portal Hypertension, Improves Liver Structure and Function in a Preclinical Model of Advanced Cirrhosis
30/04/2019
SAN DIEGO, April 30, 2019 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) today announced a new publication 1 in Hepatology Communications detailing results following seven-day treatment with emricasan, [...]
Kura Oncology to Report First Quarter 2019 Financial Results
30/04/2019
SAN DIEGO, April 30, 2019 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced that it will [...]
Avenue Therapeutics Announces Appointment of Dr. Thomas G. Moore to Board of Directors
30/04/2019
NEW YORK, April 30, 2019 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ: ATXI) (“Avenue”), a specialty pharmaceutical company focused on the development and commercialization of intravenous (IV) tramadol, today [...]
BeyondSpring Provides Business Update and Fourth Quarter and Full-Year 2018 Financial Results
30/04/2019
- Significant Clinical Data Generated for Plinabulin - - On Track to Submit New Drug Applications (NDAs) for Plinabulin to China’s National Medical Products Administration (NMPA) for Both Non-Small Cell Lung Cancer ( [...]
Aptinyx Reports Positive Data from Phase 1 Study of Novel NMDA Receptor Modulator, NYX-458, in Healthy Volunteers
30/04/2019
Favorable overall safety, tolerability, and pharmacokinetic profile — no serious adverse events reported across wide dose range Achieved ample CNS exposure consistent with exposure observed at preclinically efficacious [...]
Cure Pharmaceutical [OTCQB:CURR] to Present at the “Planet MicroCap Showcase 2019”
30/04/2019
CURE CEO to discuss expanded product pipeline and company’s continued execution into cannabinoid market. LAS VEGAS, April 30, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and [...]

Pages